Industry Research Reports

Home > Reports > Medical Care > Arthropod-borne Viral Infections Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Arthropod-borne Viral Infections Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-12

Pages: 106 Pages

Report ld: 2627607

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Arthropod-borne Viral Infections Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 233%.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Arthropod-borne Viral Infections Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Arthropod-borne Viral Infections Testing by region & country, by Type, and by Application.

The Arthropod-borne Viral Infections Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arthropod-borne Viral Infections Testing.

Market Segmentation

Report Metric
Details
Report Title
Arthropod-borne Viral Infections Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Arthropod-borne Viral Infections Testing Companies Covered
Bio-Rad, Fluke Biomedical, Agilent Technologies, Acmas Technologie, BioMed, AESKU.GROUP, Datrend System, Copley Scientific, Distek, Ahlborn
Global Arthropod-borne Viral Infections Testing Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Arthropod-borne Viral Infections Testing Market, Segment by Type
ELISA-based Tests

RT-PCR-based Tests

Immunochromatography Rapid Diagnosis
Global Arthropod-borne Viral Infections Testing Market, Segment by Application
Hospitals

Public Health Laboratories

Diagnostic Centers

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Arthropod-borne Viral Infections Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Arthropod-borne Viral Infections Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Arthropod-borne Viral Infections Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Arthropod-borne Viral Infections Testing Product Introduction
    1.2 Global Arthropod-borne Viral Infections Testing Market Size Forecast
    1.3 Arthropod-borne Viral Infections Testing Market Trends & Drivers
        1.3.1 Arthropod-borne Viral Infections Testing Industry Trends
        1.3.2 Arthropod-borne Viral Infections Testing Market Drivers & Opportunity
        1.3.3 Arthropod-borne Viral Infections Testing Market Challenges
        1.3.4 Arthropod-borne Viral Infections Testing Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Arthropod-borne Viral Infections Testing Players Revenue Ranking (2023)
    2.2 Global Arthropod-borne Viral Infections Testing Revenue by Company (2019-2024)
    2.3 Key Companies Arthropod-borne Viral Infections Testing Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Arthropod-borne Viral Infections Testing Product Offered
    2.5 Key Companies Time to Begin Mass Production of Arthropod-borne Viral Infections Testing
    2.6 Arthropod-borne Viral Infections Testing Market Competitive Analysis
        2.6.1 Arthropod-borne Viral Infections Testing Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Arthropod-borne Viral Infections Testing Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arthropod-borne Viral Infections Testing as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 ELISA-based Tests
        3.1.2 RT-PCR-based Tests
        3.1.3 Immunochromatography Rapid Diagnosis
    3.2 Global Arthropod-borne Viral Infections Testing Sales Value by Type
        3.2.1 Global Arthropod-borne Viral Infections Testing Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Arthropod-borne Viral Infections Testing Sales Value, by Type (2019-2030)
        3.2.3 Global Arthropod-borne Viral Infections Testing Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Public Health Laboratories
        4.1.3 Diagnostic Centers
        4.1.4 Others
    4.2 Global Arthropod-borne Viral Infections Testing Sales Value by Application
        4.2.1 Global Arthropod-borne Viral Infections Testing Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Arthropod-borne Viral Infections Testing Sales Value, by Application (2019-2030)
        4.2.3 Global Arthropod-borne Viral Infections Testing Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Arthropod-borne Viral Infections Testing Sales Value by Region
        5.1.1 Global Arthropod-borne Viral Infections Testing Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Arthropod-borne Viral Infections Testing Sales Value by Region (2019-2024)
        5.1.3 Global Arthropod-borne Viral Infections Testing Sales Value by Region (2025-2030)
        5.1.4 Global Arthropod-borne Viral Infections Testing Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Arthropod-borne Viral Infections Testing Sales Value, 2019-2030
        5.2.2 North America Arthropod-borne Viral Infections Testing Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Arthropod-borne Viral Infections Testing Sales Value, 2019-2030
        5.3.2 Europe Arthropod-borne Viral Infections Testing Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Arthropod-borne Viral Infections Testing Sales Value, 2019-2030
        5.4.2 Asia Pacific Arthropod-borne Viral Infections Testing Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Arthropod-borne Viral Infections Testing Sales Value, 2019-2030
        5.5.2 South America Arthropod-borne Viral Infections Testing Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Arthropod-borne Viral Infections Testing Sales Value, 2019-2030
        5.6.2 Middle East & Africa Arthropod-borne Viral Infections Testing Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Arthropod-borne Viral Infections Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Arthropod-borne Viral Infections Testing Sales Value
    6.3 United States
        6.3.1 United States Arthropod-borne Viral Infections Testing Sales Value, 2019-2030
        6.3.2 United States Arthropod-borne Viral Infections Testing Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Arthropod-borne Viral Infections Testing Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Arthropod-borne Viral Infections Testing Sales Value, 2019-2030
        6.4.2 Europe Arthropod-borne Viral Infections Testing Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Arthropod-borne Viral Infections Testing Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Arthropod-borne Viral Infections Testing Sales Value, 2019-2030
        6.5.2 China Arthropod-borne Viral Infections Testing Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Arthropod-borne Viral Infections Testing Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Arthropod-borne Viral Infections Testing Sales Value, 2019-2030
        6.6.2 Japan Arthropod-borne Viral Infections Testing Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Arthropod-borne Viral Infections Testing Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Arthropod-borne Viral Infections Testing Sales Value, 2019-2030
        6.7.2 South Korea Arthropod-borne Viral Infections Testing Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Arthropod-borne Viral Infections Testing Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Arthropod-borne Viral Infections Testing Sales Value, 2019-2030
        6.8.2 Southeast Asia Arthropod-borne Viral Infections Testing Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Arthropod-borne Viral Infections Testing Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Arthropod-borne Viral Infections Testing Sales Value, 2019-2030
        6.9.2 India Arthropod-borne Viral Infections Testing Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Arthropod-borne Viral Infections Testing Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Bio-Rad
        7.1.1 Bio-Rad Profile
        7.1.2 Bio-Rad Main Business
        7.1.3 Bio-Rad Arthropod-borne Viral Infections Testing Products, Services and Solutions
        7.1.4 Bio-Rad Arthropod-borne Viral Infections Testing Revenue (US$ Million) & (2019-2024)
        7.1.5 Bio-Rad Recent Developments
    7.2 Fluke Biomedical
        7.2.1 Fluke Biomedical Profile
        7.2.2 Fluke Biomedical Main Business
        7.2.3 Fluke Biomedical Arthropod-borne Viral Infections Testing Products, Services and Solutions
        7.2.4 Fluke Biomedical Arthropod-borne Viral Infections Testing Revenue (US$ Million) & (2019-2024)
        7.2.5 Fluke Biomedical Recent Developments
    7.3 Agilent Technologies
        7.3.1 Agilent Technologies Profile
        7.3.2 Agilent Technologies Main Business
        7.3.3 Agilent Technologies Arthropod-borne Viral Infections Testing Products, Services and Solutions
        7.3.4 Agilent Technologies Arthropod-borne Viral Infections Testing Revenue (US$ Million) & (2019-2024)
        7.3.5 Acmas Technologie Recent Developments
    7.4 Acmas Technologie
        7.4.1 Acmas Technologie Profile
        7.4.2 Acmas Technologie Main Business
        7.4.3 Acmas Technologie Arthropod-borne Viral Infections Testing Products, Services and Solutions
        7.4.4 Acmas Technologie Arthropod-borne Viral Infections Testing Revenue (US$ Million) & (2019-2024)
        7.4.5 Acmas Technologie Recent Developments
    7.5 BioMed
        7.5.1 BioMed Profile
        7.5.2 BioMed Main Business
        7.5.3 BioMed Arthropod-borne Viral Infections Testing Products, Services and Solutions
        7.5.4 BioMed Arthropod-borne Viral Infections Testing Revenue (US$ Million) & (2019-2024)
        7.5.5 BioMed Recent Developments
    7.6 AESKU.GROUP
        7.6.1 AESKU.GROUP Profile
        7.6.2 AESKU.GROUP Main Business
        7.6.3 AESKU.GROUP Arthropod-borne Viral Infections Testing Products, Services and Solutions
        7.6.4 AESKU.GROUP Arthropod-borne Viral Infections Testing Revenue (US$ Million) & (2019-2024)
        7.6.5 AESKU.GROUP Recent Developments
    7.7 Datrend System
        7.7.1 Datrend System Profile
        7.7.2 Datrend System Main Business
        7.7.3 Datrend System Arthropod-borne Viral Infections Testing Products, Services and Solutions
        7.7.4 Datrend System Arthropod-borne Viral Infections Testing Revenue (US$ Million) & (2019-2024)
        7.7.5 Datrend System Recent Developments
    7.8 Copley Scientific
        7.8.1 Copley Scientific Profile
        7.8.2 Copley Scientific Main Business
        7.8.3 Copley Scientific Arthropod-borne Viral Infections Testing Products, Services and Solutions
        7.8.4 Copley Scientific Arthropod-borne Viral Infections Testing Revenue (US$ Million) & (2019-2024)
        7.8.5 Copley Scientific Recent Developments
    7.9 Distek
        7.9.1 Distek Profile
        7.9.2 Distek Main Business
        7.9.3 Distek Arthropod-borne Viral Infections Testing Products, Services and Solutions
        7.9.4 Distek Arthropod-borne Viral Infections Testing Revenue (US$ Million) & (2019-2024)
        7.9.5 Distek Recent Developments
    7.10 Ahlborn
        7.10.1 Ahlborn Profile
        7.10.2 Ahlborn Main Business
        7.10.3 Ahlborn Arthropod-borne Viral Infections Testing Products, Services and Solutions
        7.10.4 Ahlborn Arthropod-borne Viral Infections Testing Revenue (US$ Million) & (2019-2024)
        7.10.5 Ahlborn Recent Developments

 8 Industry Chain Analysis
    8.1 Arthropod-borne Viral Infections Testing Industrial Chain
    8.2 Arthropod-borne Viral Infections Testing Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Arthropod-borne Viral Infections Testing Sales Model
        8.5.2 Sales Channel
        8.5.3 Arthropod-borne Viral Infections Testing Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Arthropod-borne Viral Infections Testing Market Trends
    Table 2. Arthropod-borne Viral Infections Testing Market Drivers & Opportunity
    Table 3. Arthropod-borne Viral Infections Testing Market Challenges
    Table 4. Arthropod-borne Viral Infections Testing Market Restraints
    Table 5. Global Arthropod-borne Viral Infections Testing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Arthropod-borne Viral Infections Testing Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Arthropod-borne Viral Infections Testing Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Arthropod-borne Viral Infections Testing Product Type
    Table 9. Key Companies Time to Begin Mass Production of Arthropod-borne Viral Infections Testing
    Table 10. Global Arthropod-borne Viral Infections Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arthropod-borne Viral Infections Testing as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Arthropod-borne Viral Infections Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Arthropod-borne Viral Infections Testing Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Arthropod-borne Viral Infections Testing Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Arthropod-borne Viral Infections Testing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Arthropod-borne Viral Infections Testing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Arthropod-borne Viral Infections Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Arthropod-borne Viral Infections Testing Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Arthropod-borne Viral Infections Testing Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Arthropod-borne Viral Infections Testing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Arthropod-borne Viral Infections Testing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Arthropod-borne Viral Infections Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Arthropod-borne Viral Infections Testing Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Arthropod-borne Viral Infections Testing Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Arthropod-borne Viral Infections Testing Sales Value by Region (2019-2024) & (%)
    Table 27. Global Arthropod-borne Viral Infections Testing Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Arthropod-borne Viral Infections Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Arthropod-borne Viral Infections Testing Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Arthropod-borne Viral Infections Testing Sales Value, (2025-2030) & (US$ Million)
    Table 31. Bio-Rad Basic Information List
    Table 32. Bio-Rad Description and Business Overview
    Table 33. Bio-Rad Arthropod-borne Viral Infections Testing Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Arthropod-borne Viral Infections Testing Business of Bio-Rad (2019-2024)
    Table 35. Bio-Rad Recent Developments
    Table 36. Fluke Biomedical Basic Information List
    Table 37. Fluke Biomedical Description and Business Overview
    Table 38. Fluke Biomedical Arthropod-borne Viral Infections Testing Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Arthropod-borne Viral Infections Testing Business of Fluke Biomedical (2019-2024)
    Table 40. Fluke Biomedical Recent Developments
    Table 41. Agilent Technologies Basic Information List
    Table 42. Agilent Technologies Description and Business Overview
    Table 43. Agilent Technologies Arthropod-borne Viral Infections Testing Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Arthropod-borne Viral Infections Testing Business of Agilent Technologies (2019-2024)
    Table 45. Agilent Technologies Recent Developments
    Table 46. Acmas Technologie Basic Information List
    Table 47. Acmas Technologie Description and Business Overview
    Table 48. Acmas Technologie Arthropod-borne Viral Infections Testing Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Arthropod-borne Viral Infections Testing Business of Acmas Technologie (2019-2024)
    Table 50. Acmas Technologie Recent Developments
    Table 51. BioMed Basic Information List
    Table 52. BioMed Description and Business Overview
    Table 53. BioMed Arthropod-borne Viral Infections Testing Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Arthropod-borne Viral Infections Testing Business of BioMed (2019-2024)
    Table 55. BioMed Recent Developments
    Table 56. AESKU.GROUP Basic Information List
    Table 57. AESKU.GROUP Description and Business Overview
    Table 58. AESKU.GROUP Arthropod-borne Viral Infections Testing Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Arthropod-borne Viral Infections Testing Business of AESKU.GROUP (2019-2024)
    Table 60. AESKU.GROUP Recent Developments
    Table 61. Datrend System Basic Information List
    Table 62. Datrend System Description and Business Overview
    Table 63. Datrend System Arthropod-borne Viral Infections Testing Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Arthropod-borne Viral Infections Testing Business of Datrend System (2019-2024)
    Table 65. Datrend System Recent Developments
    Table 66. Copley Scientific Basic Information List
    Table 67. Copley Scientific Description and Business Overview
    Table 68. Copley Scientific Arthropod-borne Viral Infections Testing Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Arthropod-borne Viral Infections Testing Business of Copley Scientific (2019-2024)
    Table 70. Copley Scientific Recent Developments
    Table 71. Distek Basic Information List
    Table 72. Distek Description and Business Overview
    Table 73. Distek Arthropod-borne Viral Infections Testing Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Arthropod-borne Viral Infections Testing Business of Distek (2019-2024)
    Table 75. Distek Recent Developments
    Table 76. Ahlborn Basic Information List
    Table 77. Ahlborn Description and Business Overview
    Table 78. Ahlborn Arthropod-borne Viral Infections Testing Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Arthropod-borne Viral Infections Testing Business of Ahlborn (2019-2024)
    Table 80. Ahlborn Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Arthropod-borne Viral Infections Testing Downstream Customers
    Table 84. Arthropod-borne Viral Infections Testing Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Arthropod-borne Viral Infections Testing Product Picture
    Figure 2. Global Arthropod-borne Viral Infections Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Arthropod-borne Viral Infections Testing Sales Value (2019-2030) & (US$ Million)
    Figure 4. Arthropod-borne Viral Infections Testing Report Years Considered
    Figure 5. Global Arthropod-borne Viral Infections Testing Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Arthropod-borne Viral Infections Testing Revenue in 2023
    Figure 7. Arthropod-borne Viral Infections Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. ELISA-based Tests Picture
    Figure 9. RT-PCR-based Tests Picture
    Figure 10. Immunochromatography Rapid Diagnosis Picture
    Figure 11. Global Arthropod-borne Viral Infections Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Arthropod-borne Viral Infections Testing Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Hospitals
    Figure 14. Product Picture of Public Health Laboratories
    Figure 15. Product Picture of Diagnostic Centers
    Figure 16. Product Picture of Others
    Figure 17. Global Arthropod-borne Viral Infections Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Arthropod-borne Viral Infections Testing Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Arthropod-borne Viral Infections Testing Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Arthropod-borne Viral Infections Testing Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Arthropod-borne Viral Infections Testing Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Arthropod-borne Viral Infections Testing Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Arthropod-borne Viral Infections Testing Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Arthropod-borne Viral Infections Testing Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Arthropod-borne Viral Infections Testing Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Arthropod-borne Viral Infections Testing Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Arthropod-borne Viral Infections Testing Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Arthropod-borne Viral Infections Testing Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Arthropod-borne Viral Infections Testing Sales Value (%), (2019-2030)
    Figure 30. United States Arthropod-borne Viral Infections Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Arthropod-borne Viral Infections Testing Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Arthropod-borne Viral Infections Testing Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Arthropod-borne Viral Infections Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Arthropod-borne Viral Infections Testing Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Arthropod-borne Viral Infections Testing Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Arthropod-borne Viral Infections Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Arthropod-borne Viral Infections Testing Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Arthropod-borne Viral Infections Testing Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Arthropod-borne Viral Infections Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Arthropod-borne Viral Infections Testing Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Arthropod-borne Viral Infections Testing Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Arthropod-borne Viral Infections Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Arthropod-borne Viral Infections Testing Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Arthropod-borne Viral Infections Testing Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Arthropod-borne Viral Infections Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Arthropod-borne Viral Infections Testing Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Arthropod-borne Viral Infections Testing Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Arthropod-borne Viral Infections Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Arthropod-borne Viral Infections Testing Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Arthropod-borne Viral Infections Testing Sales Value by Application (%), 2023 VS 2030
    Figure 51. Arthropod-borne Viral Infections Testing Industrial Chain
    Figure 52. Arthropod-borne Viral Infections Testing Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation

Description

The global market for Arthropod-borne Viral Infections Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 233%.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Arthropod-borne Viral Infections Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Arthropod-borne Viral Infections Testing by region & country, by Type, and by Application.

The Arthropod-borne Viral Infections Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arthropod-borne Viral Infections Testing.

Market Segmentation